[Special Stock] Samsung Biologics Surges on Q3 Earnings Surprise

[Asia Economy Reporter Song Hwajeong] Samsung Biologics' stock price is strong following its robust performance in the third quarter of this year.

As of 10:33 AM on the 27th, Samsung Biologics was trading at 899,000 KRW, up 20,000 KRW (2.28%) from the previous day.

The surprise earnings in the third quarter appear to have driven the stock price increase. Samsung Biologics' third-quarter results significantly exceeded expectations. The company announced that its consolidated sales for the third quarter reached 450.733 billion KRW, and operating profit was 167.411 billion KRW. These figures represent increases of 64.15% and 196.12%, respectively, compared to the same period last year. This marks the second consecutive quarter of record quarterly performance. Market consensus estimates were also surpassed by 9.6% and 26%, respectively.